Luteinizing Hormone-releasing Hormone Analogue and Enzalutamide +/- Zoledronic Acid in Prostate Cancer Patients

NCT03336983 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

126

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer
Bone Metastases

Interventions

DRUG: Zoledronic Acid
DRUG: Enzalutamide

Sponsor

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia